IMDX · Insight Molecular Diagnostics Inc
United States · RS rating 11 · As of 2026-11-03
| Price | 2.74 USD |
|---|---|
| 1-day change | -4.2% |
| RS rating (overall / 1M / 3M / 12M) | 11 / 16 / 11 / 19 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 5 / 19 |
| Industry group (rank) | Medical-Research Eqp/Svc (46) |
| EPS growth Q/Q | -111.8% |
| Sales growth Q/Q | +338.1% |
| Distance from 52-week high | +67.7% |
| Market cap (USD) | $113.2M |